drugset / Trial / NCT02508753
Safety Study Designed to Study the Effects of Two Different Doses of CXA-101/Tazobactam, a Low Dose and a High Dose, on the QT/QTc Intervals in Healthy Subjects
RandomizedCrossoverDouble-blindOther
Summary
The purpose of the study is look at the possible side effects of two different doses of CXA-101/tazobactam, a low dose and a high dose, on participant's heart.
Timeline
- Start
- 2010-06
- Primary completion
- 2010-07
- Completion
- 2010-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ceftolozane | Small molecule | 1000 mg | Intravenous |
| Subject | Ceftolozane | Small molecule | 3000 mg | Intravenous |
| Comparator | Moxifloxacin | Small molecule | 400 mg | — |
| Subject | Tazobactam | Small molecule | 500 mg | Intravenous |
| Subject | Tazobactam | Small molecule | 1500 mg | Intravenous |
Indications
No indication recorded.